Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Rivastigmine Is a Potent Inhibitor of Cholinesterases in Plaques and Tangles
111
Authors/Disclosures
Bhaskar Roy, MD, FÂé¶¹´«Ã½Ó³»­ (Yale University) Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Roy has or had stock in Cabaletta bio. .Dr. Roy has or had stock in Pfizer.Dr. Roy has or had stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
No disclosure on file
No disclosure on file
Charles H. Whitaker, MD (Hospital for Special Care) No disclosure on file
No disclosure on file
Kevin Felice, DO (Hospital for Special Care) No disclosure on file